KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Tax ProvisionsTax Rate
Others
Ratios

BioNTech SE (BNTX) Profit After Tax (2018 - 2025)

Historic Profit After Tax for BioNTech SE (BNTX) over the last 8 years, with Q3 2025 value amounting to -$33.6 million.

  • BioNTech SE's Profit After Tax fell 11542.21% to -$33.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$631.2 million, marking a year-over-year decrease of 2574.71%. This contributed to the annual value of -$710.9 million for FY2024, which is 17102.64% down from last year.
  • As of Q3 2025, BioNTech SE's Profit After Tax stood at -$33.6 million, which was down 11542.21% from -$437.6 million recorded in Q2 2025.
  • In the past 5 years, BioNTech SE's Profit After Tax ranged from a high of $4.2 billion in Q1 2022 and a low of -$869.9 million during Q2 2024
  • In the last 5 years, BioNTech SE's Profit After Tax had a median value of $277.3 million in 2024 and averaged $1.1 billion.
  • Per our database at Business Quant, BioNTech SE's Profit After Tax soared by 82798755377.65% in 2021 and then plummeted by 31957.5% in 2024.
  • Quarter analysis of 5 years shows BioNTech SE's Profit After Tax stood at $3.6 billion in 2021, then tumbled by 35.81% to $2.3 billion in 2022, then tumbled by 78.81% to $492.7 million in 2023, then tumbled by 43.72% to $277.3 million in 2024, then plummeted by 112.1% to -$33.6 million in 2025.
  • Its last three reported values are -$33.6 million in Q3 2025, -$437.6 million for Q2 2025, and -$437.4 million during Q1 2025.